| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |